Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy

NCT: NCT07467798 · NOT_YET_RECRUITING

NCT IDNCT07467798
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2027-11

Brief Summary

The objective of this clinical study is to evaluate the initial efficacy and safety of LIPUS as an adjunct to standard therapy in patients with shock. The investigators will invite patients to participate in a proof-of-concept study investigating the efficacy of neck ultrasound stimulation to enhance anti-shock treatment, involving brief exposure to low-intensity pulsed ultrasound. This study examines whether LIPUS can enhance blood pressure in patients with shock, improve the efficacy of antihypotensive treatment, and reduce the dosage and duration of vasoactive drugs during active pharmacological therapy. By applying LIPUS as an adjunct to conventional treatment in clinical cases of shock, we aim to determine the clinical value of LIPUS and establish a theoretical foundation for developing innovative new therapies for shock.

Frequently Asked Questions

What is A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy?

A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy is a clinical trial registered under NCT07467798. Current status: NOT_YET_RECRUITING.

What is the status of NCT07467798?

The current status of NCT07467798 (A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy) is: NOT_YET_RECRUITING.

When did A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy start?

A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.